$BIOAQ
Throughout the process, BioAmber is successfully serving our customer base and continues to supply high-quality bio-succinic acid to companies around the world. We would like to thank our customers for their support and willingness to work with us through this process. With this favorable court decision, we are pleased to be able to continue operations in Sarnia to meet the growing demand we’re seeing from the market,” stated Rick Eno, Chief Executive Officer. “In the longer term, BioAmber has a number of strategic and financial investors evaluating an investment as part of the SISP. We are optimistic that the closing of a transaction will provide our customers long-term supply assurance from the Sarnia facility. We will continue to provide updates throughout the process.”
Earning a current market cap value of $9.2M, BIOAQ has a significant war chest ($4.6M) of cash on the books, which compares with about $4.9M in total current liabilities. BIOAQ is pulling in trailing 12-month revenues of $14.9M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 754.6%. This is an exciting story, and we look forward to a follow-up chapter as events transpire.
